{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:23:41Z","timestamp":1791037421723,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,26]],"date-time":"2011-01-26T00:00:00Z","timestamp":1296000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2369-12-3","type":"journal-article","created":{"date-parts":[[2011,1,26]],"date-time":"2011-01-26T19:20:12Z","timestamp":1296069612000},"source":"Crossref","is-referenced-by-count":63,"title":["Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis"],"prefix":"10.1186","volume":"12","author":[{"given":"Ruth","family":"Dubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R","family":"Folsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda F","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Palmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen A","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,26]]},"reference":[{"key":"190_CR1","volume-title":"Definition and Classification of Stages of Chronic Kidney Disease","author":"KDOQI","year":"2002","unstructured":"KDOQI: Definition and Classification of Stages of Chronic Kidney Disease. 2002, [ http:\/\/www.kidney.org\/professionals\/kdoqi\/guidelines_ckd\/p4_class_g2.htm ]"},{"issue":"1","key":"190_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00041552-200401000-00011","volume":"13","author":"J Coresh","year":"2004","unstructured":"Coresh J, Astor B, Sarnak MJ: Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2004, 13 (1): 73-81.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"190_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","volume":"116","author":"EL Schiffrin","year":"2007","unstructured":"Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007, 116 (1): 85-97.","journal-title":"Circulation"},{"issue":"4","key":"190_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","volume":"145","author":"MG Shlipak","year":"2006","unstructured":"Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, et al: Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006, 145 (4): 237-46.","journal-title":"Ann Intern Med"},{"issue":"20","key":"190_CR5","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1056\/NEJMoa043161","volume":"352","author":"MG Shlipak","year":"2005","unstructured":"Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005, 352 (20): 2049-60.","journal-title":"N Engl J Med"},{"issue":"1","key":"190_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1681\/ASN.2005050545","volume":"17","author":"MG Shlipak","year":"2006","unstructured":"Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, et al: Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. 2006, 17 (1): 254-61.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"190_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2215\/CJN.03670807","volume":"3","author":"P Stenvinkel","year":"2008","unstructured":"Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?. Clin J Am Soc Nephrol. 2008, 3 (2): 505-21.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"190_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","volume":"58","author":"AK Cheung","year":"2000","unstructured":"Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000, 58 (1): 353-62.","journal-title":"Kidney Int"},{"issue":"2","key":"190_CR9","first-page":"63","volume":"26","author":"ZA Massy","year":"2005","unstructured":"Massy ZA, Taupin P, Jungers P, Landais P: Prediction model of coronary heart disease in patients with chronic kidney disease: role of plasma fibrinogen as a new prognostic variable. Prilozi. 2005, 26 (2): 63-77.","journal-title":"Prilozi"},{"issue":"12","key":"190_CR10","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1093\/ndt\/gfm424","volume":"22","author":"DM Spiegel","year":"2007","unstructured":"Spiegel DM, Raggi P, Smits G, Block GA: Factors associated with mortality in patients new to haemodialysis. Nephrol Dial Transplant. 2007, 22 (12): 3568-72.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"190_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrcardio.2009.80","volume":"6","author":"FA Hellenthal","year":"2009","unstructured":"Hellenthal FA, Buurman WA, Wodzig WK, Schurink GW: Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol. 2009, 6 (7): 464-74.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"190_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1076-7460.2004.02125.x","volume":"13","author":"MG Shlipak","year":"2004","unstructured":"Shlipak MG, Fried LF, Stehman-Breen C, Siscovick D, Newman AB: Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study. Am J Geriatr Cardiol. 2004, 13 (2): 81-90.","journal-title":"Am J Geriatr Cardiol"},{"issue":"12","key":"190_CR13","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.07.060","volume":"118","author":"MG Shlipak","year":"2005","unstructured":"Shlipak MG, Katz R, Cushman M, Sarnak MJ, Stehman-Breen C, Psaty BM, et al: Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med. 2005, 118 (12): 1416-","journal-title":"Am J Med"},{"issue":"1","key":"190_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/ndt\/gfp429","volume":"25","author":"C Keller","year":"2010","unstructured":"Keller C, Katz R, Sarnak MJ, Fried LF, Kestenbaum B, Cushman M, et al: Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study. Nephrol Dial Transplant. 2010, 25 (1): 119-24.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"190_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.ki.5002042","volume":"71","author":"CR Keller","year":"2007","unstructured":"Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, et al: Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int. 2007, 71 (3): 239-44.","journal-title":"Kidney Int"},{"issue":"4","key":"190_CR16","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/ndt\/gfl744","volume":"22","author":"D Singh","year":"2007","unstructured":"Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG: Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant. 2007, 22 (4): 1087-92.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"190_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","volume":"156","author":"DE Bild","year":"2002","unstructured":"Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al: Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002, 156 (9): 871-81.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"190_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","volume":"51","author":"LA Stevens","year":"2008","unstructured":"Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008, 51 (3): 395-406.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"190_CR19","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/j.1523-1755.2005.00608.x","volume":"68","author":"K Murthy","year":"2005","unstructured":"Murthy K, Stevens LA, Stark PC, Levey AS: Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. Kidney Int. 2005, 68 (4): 1884-7.","journal-title":"Kidney Int"},{"issue":"9","key":"190_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-12.","journal-title":"Ann Intern Med"},{"issue":"1","key":"190_CR21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood.V71.1.220.bloodjournal711220","volume":"71","author":"PJ Declerck","year":"1988","unstructured":"Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, Collen D: Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood. 1988, 71 (1): 220-5.","journal-title":"Blood"},{"issue":"19","key":"190_CR22","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-72.","journal-title":"JAMA"},{"issue":"1","key":"190_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0049-3848(00)00216-4","volume":"99","author":"M Nakano","year":"2000","unstructured":"Nakano M, Furutani M, Shinno H, Ikeda T, Oida K, Ishii H: Elevation of soluble thrombomodulin antigen levels in the serum and urine of streptozotocin-induced diabetes model rats. Thromb Res. 2000, 99 (1): 83-91.","journal-title":"Thromb Res"},{"issue":"1","key":"190_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000046673","volume":"22","author":"SH Jacobson","year":"2002","unstructured":"Jacobson SH, Egberg N, Hylander B, Lundahl J: Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol. 2002, 22 (1): 42-7.","journal-title":"Am J Nephrol"},{"issue":"6","key":"190_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0049-3848(97)00280-6","volume":"88","author":"D Mezzano","year":"1997","unstructured":"Mezzano D, Tagle R, Pais E, Panes O, Perez M, Downey P, et al: Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure. Thromb Res. 1997, 88 (6): 465-72.","journal-title":"Thromb Res"},{"issue":"4","key":"190_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00041433-200308000-00006","volume":"14","author":"KK Wu","year":"2003","unstructured":"Wu KK: Soluble thrombomodulin and coronary heart disease. Curr Opin Lipidol. 2003, 14 (4): 373-5.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"190_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1253\/circj.CJ-09-0818","volume":"74","author":"A Breitenstein","year":"2010","unstructured":"Breitenstein A, Tanner FC, Luscher TF: Tissue factor and cardiovascular disease. Circ J. 2010, 74 (1): 3-12.","journal-title":"Circ J"},{"issue":"3","key":"190_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1538-7836.2007.02402.x","volume":"5","author":"V Toschi","year":"2007","unstructured":"Toschi V: Soluble tissue factor and tissue factor pathway inhibitor in cardiovascular disease. J Thromb Haemost. 2007, 5 (3): 472-4.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"190_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.thromres.2008.03.024","volume":"123","author":"MJ Adams","year":"2008","unstructured":"Adams MJ, Irish AB, Watts GF, Oostryck R, Dogra GK: Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function. Thromb Res. 2008, 123 (2): 374-80.","journal-title":"Thromb Res"},{"issue":"3","key":"190_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1538-7836.2007.02372.x","volume":"5","author":"PE Morange","year":"2007","unstructured":"Morange PE, Blankenberg S, Alessi MC, Bickel C, Rupprecht HJ, Schnabel R, et al: Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost. 2007, 5 (3): 475-82.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"190_CR31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/01.ATV.21.4.611","volume":"21","author":"AR Folsom","year":"2001","unstructured":"Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK: Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol. 2001, 21 (4): 611-7.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"190_CR32","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1093\/eurheartj\/ehl402","volume":"27","author":"SG Wannamethee","year":"2006","unstructured":"Wannamethee SG, Shaper AG, Lowe GD, Lennon L, Rumley A, Whincup PH: Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers. Eur Heart J. 2006, 27 (24): 2975-81.","journal-title":"Eur Heart J"},{"issue":"9","key":"190_CR33","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/01.ATV.18.9.1359","volume":"18","author":"PM Mannucci","year":"1998","unstructured":"Mannucci PM: von Willebrand factor: a marker of endothelial damage?. Arterioscler Thromb Vasc Biol. 1998, 18 (9): 1359-62.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"190_CR34","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1056\/NEJMoa032804","volume":"350","author":"J Danesh","year":"2004","unstructured":"Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004, 350 (14): 1387-97.","journal-title":"N Engl J Med"},{"issue":"1","key":"190_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1365-2141.1999.01317.x","volume":"105","author":"A Rumley","year":"1999","unstructured":"Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP: Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Br J Haematol. 1999, 105 (1): 110-6.","journal-title":"Br J Haematol"},{"issue":"4","key":"190_CR36","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1053\/j.ajkd.2008.10.044","volume":"53","author":"LD Bash","year":"2009","unstructured":"Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC: Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009, 53 (4): 596-605.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"190_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ajh.21429","volume":"84","author":"AR Folsom","year":"2009","unstructured":"Folsom AR, Delaney JA, Lutsey PL, Zakai NA, Jenny NS, Polak JF, et al: Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. Am J Hematol. 2009, 84 (6): 349-53.","journal-title":"Am J Hematol"},{"issue":"12","key":"190_CR38","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1161\/01.ATV.0000249406.92992.0d","volume":"26","author":"PE Morange","year":"2006","unstructured":"Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D, et al: Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol. 2006, 26 (12): 2793-9.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"190_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/01.ATV.19.3.493","volume":"19","author":"M Cushman","year":"1999","unstructured":"Cushman M, Lemaitre RN, Kuller LH, Psaty BM, Macy EM, Sharrett AR, et al: Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999, 19 (3): 493-8.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"190_CR40","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1538-7836.2006.01935.x","volume":"4","author":"S Shrivastava","year":"2006","unstructured":"Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, et al: D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost. 2006, 4 (6): 1208-14.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"190_CR41","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MCP.0b013e32832ee371","volume":"15","author":"K Wattanakit","year":"2009","unstructured":"Wattanakit K, Cushman M: Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms. Curr Opin Pulm Med. 2009, 15 (5): 408-12.","journal-title":"Curr Opin Pulm Med"},{"key":"190_CR42","volume-title":"Nephrol Dial Transplant","author":"AR Folsom","year":"2010","unstructured":"Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M: Chronic kidney disease and venous thromboembolism: a prospective study. Nephrol Dial Transplant. 2010"},{"issue":"2","key":"190_CR43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0038-1645037","volume":"63","author":"H Ishii","year":"1990","unstructured":"Ishii H, Nakano M, Tsubouchi J, Ishikawa T, Uchiyama H, Hiraishi S, et al: Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haemost. 1990, 63 (2): 157-62.","journal-title":"Thromb Haemost"},{"issue":"3","key":"190_CR44","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/jcp.52.3.219","volume":"52","author":"BA Lwaleed","year":"1999","unstructured":"Lwaleed BA, Chisholm M, Francis JL: Development and validation of an assay for urinary tissue factor activity. J Clin Pathol. 1999, 52 (3): 219-24.","journal-title":"J Clin Pathol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-12-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T01:30:56Z","timestamp":1592271056000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-12-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,26]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-12-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,26]]},"article-number":"3"}}